| Finegoldia | |
|---|---|
| Scientific classification | |
| Domain: | |
| Phylum: | |
| Class: | |
| Order: | |
| Family: | |
| Genus: | Finegoldia Murdoch & Shah 2000 |
| Type species | |
| Finegoldia magna (Prévot 1933) Murdoch & Shah 2000 | |
| Species | |
| |
Finegoldia is a genus of Gram-positive bacteria. They are anaerobic cocci of the class Clostridia, with Finegoldia magna being the type species. [1] F. magna was formerly known, along with several other Gram-positive anaerobic cocci (GPACs), as Peptostreptococcus magnus, but was moved into its own genus in 1999. [2] [3] The name is in honor of Sydney M. Finegold, an American microbiologist, while magna is Latin for large. [1] It is an opportunistic human pathogen that normally colonizes skin and mucous membranes. [4] It is often seen in biofilms on chronic ulcers such as in diabetic foot or decubitus ulcers. [3] Most surveys have found it to be susceptible to penicillins, carbapenems and metronidazole, though resistant strains have been identified. [5] Resistance to clindamycin is common and has been seen in over 10% of isolates in the US. [3] [6] One review stated that "the combination of diminished antimicrobial susceptibility, its prevalence, and the described virulence factors gives F. magna a special position among the GPAC." [5]